Free Trial

Aprea Therapeutics (APRE) Institutional Ownership

Aprea Therapeutics logo
$0.84 +0.00 (+0.29%)
Closing price 04:00 PM Eastern
Extended Trading
$0.81 -0.04 (-4.41%)
As of 05:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Aprea Therapeutics (NASDAQ:APRE)

Current
Institutional Ownership
Percentage
34.19%
Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$634.75K
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$441.72K
Get APRE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Aprea Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

APRE Institutional Buying and Selling by Quarter

Aprea Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/30/2026 AIGH Capital Management LLC1,015,541$775K0.1%+174.1%8.475%
2/12/2026Jane Street Group LLC46,621$40K0.0%N/A0.667%
2/12/2026DRW Securities LLC120,651$103K0.0%N/A1.725%
2/2/2026 AIGH Capital Management LLC370,541$316K0.1%-31.3%5.301%
5/16/2025Exome Asset Management LLC28,972$59K0.1%-77.4%0.524%
5/14/2025Stonepine Capital Management LLC102,242$209K0.2%-31.5%1.851%
2/17/2025Stonepine Capital Management LLC149,221$491K0.4%+8.8%2.748%
2/17/2025BNP Paribas Financial Markets13,011$43K0.0%N/A0.240%
2/12/2025Landscape Capital Management L.L.C.35,328$116K0.0%N/A0.651%
2/11/2025LPL Financial LLC16,052$53K0.0%N/A0.296%
8/21/2024Stonepine Capital Management LLC137,174$558K0.5%N/A2.526%
8/9/2024Dimensional Fund Advisors LP11,071$45K0.0%N/A0.204%
5/15/2023AIGH Capital Management LLC345,000$1.53M0.6%N/A9.244%
5/15/2023Sio Capital Management LLC280,000$1.24M0.6%N/A7.503%
5/12/2022Gyon Technologies Capital Management LP20,570$38K0.0%N/A0.094%
5/12/2022Magnus Financial Group LLC14,856$28K0.0%-56.3%0.068%
2/15/2022Kennedy Capital Management Inc.336,730$966K0.0%-1.7%1.569%
2/14/2022PDT Partners LLC142,600$409K0.0%+62.5%0.664%
2/10/2022Magnus Financial Group LLC33,981$98K0.0%N/A0.158%


APRE Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of APRE shares?

During the previous two years, 9 institutional investors and hedge funds held shares of Aprea Therapeutics. The most heavily invested institutionals were AIGH Capital Management LLC ($775K), Stonepine Capital Management LLC ($209K), Landscape Capital Management L.L.C. ($116K), DRW Securities LLC ($103K), Exome Asset Management LLC ($59K), LPL Financial LLC ($53K), and Dimensional Fund Advisors LP ($45K).Learn more on Aprea Therapeutics' institutional investors.

What percentage of Aprea Therapeutics' stock is owned by institutional investors?

34.19% of Aprea Therapeutics' stock is owned by institutional investors. Learn more on APRE's institutional investor holdings.

Which institutional investors have been buying Aprea Therapeutics' stock?

The following institutional investors have purchased Aprea Therapeutics' stock in the last 24 months: AIGH Capital Management LLC ($645K), Stonepine Capital Management LLC ($149.22K), DRW Securities LLC ($120.65K), Jane Street Group LLC ($46.62K), Landscape Capital Management L.L.C. ($35.33K), LPL Financial LLC ($16.05K), and BNP Paribas Financial Markets ($13.01K).

How much institutional buying is happening at Aprea Therapeutics?

Institutional investors have bought a total of 812,272 shares in the last 24 months. This purchase volume represents approximately $634.75K in transactions.

Which of Aprea Therapeutics' major shareholders have been selling company stock?

The following institutional investors have sold Aprea Therapeutics stock in the last 24 months: AIGH Capital Management LLC ($168.76K), Exome Asset Management LLC ($98.99K), and Stonepine Capital Management LLC ($46.98K).

How much institutional selling is happening at Aprea Therapeutics?

Institutional investors have sold a total of 314,726 shares in the last 24 months. This volume of shares sold represents approximately $441.72K in transactions.



This page (NASDAQ:APRE) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners